The overall biologics market was $135 billion in 2009, and is expected to grow to $149 billion in 2010, a 9.4% growth rate. The total market is expected to grow to $239 billion by 2015, a compound annual growth rate (CAGR) of 9.9% since 2010.
Learn about the market for biologics, or biopharmaceuticals, on a global basis. This report includes chapters on industry structure and competitive analysis, markets by product type and disease, biologics manufacturing, pipeline analysis and relevant company profiles…
Use this report to:
- Understand the factors that will advance biologics, or large molecule drug.
- Anticipate and prepare for programs that are expected to dominate the biopharmaceutical marketplace and change market dynamics in the coming years.
- Develop strategies to access emerging markets, specific disease segments, and geographies in order to allocate resources and make effective decisions.
- Learn about the strategies of companies poised to introduce novel products during the forecast period, how these introductions will change the competitive environment, and how new products and technologies are influencing the current standard of care.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.